Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Invested Capital (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Invested Capital for 7 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 76.87% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 76.87% year-over-year, with the annual reading at $1.5 million for FY2025, 76.87% up from the prior year.
  • Invested Capital for Q4 2025 was $1.5 million at BioScience Health Innovations, down from $1.7 million in the prior quarter.
  • The five-year high for Invested Capital was $1.7 million in Q2 2025, with the low at -$88990.0 in Q1 2023.
  • Average Invested Capital over 5 years is $386012.9, with a median of $41980.5 recorded in 2022.
  • The sharpest move saw Invested Capital plummeted 130.04% in 2021, then surged 12455.62% in 2024.
  • Over 5 years, Invested Capital stood at $76012.0 in 2021, then plummeted by 66.48% to $25476.0 in 2022, then tumbled by 126.53% to -$6760.0 in 2023, then soared by 12455.62% to $835240.0 in 2024, then soared by 76.87% to $1.5 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $1.5 million, $1.7 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.